Daito Pharmaceutical (4577) · InitiativeRestated
Mitigating Foreign Exchange and Interest Rate Fluctuation Risks Through Derivatives
First written in FY2018. 1 of 3 entries say "Softened", first in FY2020. Latest entry: FY2025.
3entries
8years
0from disclosures
How it moved
Same theme, other companies
Hedging Policy for Foreign Exchange and Interest Rate RisksA theme 76 companies write about · 19 as a headwind · 57 as a tailwind
47 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 76 companies compared. The sentences above are computed from all 76.Full recordFilings, disclosures and news, newest first
- FY2025RestatedAnnual report
「Derivatives are used to mitigate foreign exchange risk associated with importing raw materials; no speculative transactions are conducted.」
The company continues its policy of limiting the use of derivatives to mitigating foreign exchange risk associated with importing raw materials. - FY2020SoftenedAnnual report
「Derivatives are used to mitigate foreign exchange risk associated with importing raw materials; no speculative transactions are conducted.」
The response to interest rate risk on borrowings, which had been stated previously, is no longer specified, and the purpose of using derivatives is limited to addressing foreign exchange risk associated with raw material imports. - FY2018First statedAnnual report
「Derivatives are used to mitigate foreign exchange risk associated with importing raw materials and interest rate risk on borrowings; no speculative transactions are conducted.」
The policy on using derivatives to address foreign exchange risk on raw material imports and interest rate risk on borrowings is being covered in a thread for the first time.